The objective is to help Konica Minolta and acquired companies in decision-making for R & D, and to accelerate the development of companion diagnostic (CDx) technologies and services.
Nikkei Biotech news release, November 28, 2018
Konica-Minolta establishs subsidiary “Precision Medicine Japan”